Argeron BioAgeCheck® vs Epigenetic Clocks

Two Fundamentally Different Approaches to Aging Measurement

Aging can be assessed in different ways, but not all aging measurements answer the same question.

Epigenetic clocks estimate how old a biological system appears to be.

Argeron BioAgeCheck® measures how fast biological aging is progressing.

This distinction is critical for clinical relevance and decision-making.

What Epigenetic Clocks Measure

Epigenetic clocks are based on DNA methylation patterns that correlate statistically with chronological age.

They provide:

  • A static biological age estimate
  • Population-level insights
  • Retrospective aging correlations

Epigenetic clocks answer the question:

"How old does this biology look right now?"

What BioAgeCheck® Measures

BioAgeCheck® is a patented LC-MS diagnostic kit developed by Argeron Medical to measure biological aging rate.

It quantifies protein deamidation kinetics, a chemically irreversible process that accumulates progressively over time.

BioAgeCheck® answers a different question:

"How fast is this biology changing?"

Static Age vs Dynamic Rate

Biological age and biological aging rate are often conflated, but they represent distinct dimensions:

  • Biological age → a snapshot
  • Biological aging rate → a trajectory

Two individuals may have the same biological age but very different aging rates, leading to divergent future outcomes.

Core Scientific Differences

Feature Epigenetic Clocks Argeron BioAgeCheck®
Primary output Biological age Biological aging rate
Biomolecular substrate DNA Protein
Molecular process DNA methylation (context-sensitive) Deamidation (irreversible)
Measurement type Static, cross-sectional Kinetic, longitudinal
Platform NGS / microarray LC-MS
Clinical independence Often model-dependent Works without AI
Longitudinal monitoring Limited Designed for it
Clinical actionability Variable High

Why Irreversibility Matters

Protein deamidation represents cumulative molecular damage that cannot be reversed under physiological conditions.

This makes it particularly suitable for:

  • Tracking aging progression over time
  • Detecting acceleration or deceleration of aging
  • Evaluating intervention effects

In contrast, DNA methylation patterns may fluctuate with:

  • Environmental changes
  • Acute physiological states
  • Short-term interventions

Clinical Implications

Epigenetic clocks are powerful tools for:

  • Population studies
  • Epidemiological research
  • Retrospective aging analysis

Argeron BioAgeCheck® is designed for:

  • Early detection of accelerated aging
  • Longitudinal patient monitoring
  • Risk stratification before disease onset
  • Clinical decision support workflows

The two approaches are complementary, not mutually exclusive — but they serve different purposes.

Role of Artificial Intelligence

In the Argeron BioAgeCheck® system:

  • The diagnostic kit independently measures biological aging rate
  • Artificial intelligence, when used, functions only as post-measurement decision support
  • AI does not influence or generate the diagnostic result

This preserves transparency, reproducibility, and clinical trust.

Summary

  • Epigenetic clocks estimate how old biology appears
  • Argeron BioAgeCheck® measures how fast biology is aging
  • Protein deamidation provides an irreversible, cumulative signal
  • Argeron BioAgeCheck® is based on a patented LC-MS diagnostic kit
  • The system is designed for dynamic, longitudinal, clinically actionable assessment

Age is a snapshot.
Aging rate is a trajectory.
Argeron BioAgeCheck® measures the trajectory.